A MULTICENTER, DOUBLE-BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY AND TOLERANCE OF SULINDAC VERSUS PLACEBO IN THE SYMPTOMATIC TREATMENT OF PATIENTS WITH UPPER RESPIRATORY-TRACT INFECTION

被引：9
|
作者：
EBEL, DL [1 ]
SHIH, WJ [1 ]
RHYMER, AR [1 ]
机构：
[1] MERCK SHARP & DOHME RES CORP,CLIN BIOSTAT INT,RAHWAY,PA
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 1985年 / 9卷 / 10期
关键词：
D O I：
10.1185/03007998509109649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 675
页数：10
相关论文
共 50 条
  • [41] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF GIANT CELL ARTERITIS
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2014, 53 : 7 - 7
  • [42] Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms:: A randomized double-blind multicenter trial
    Möller, HJ
    Riedel, M
    Müller, N
    Fischer, W
    Kohnen, R
    PHARMACOPSYCHIATRY, 2004, 37 (06) : 270 - 278
  • [43] Cidofovir efficacy in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled study
    McMurray, J. Scott
    Connor, Nadine
    Ford, Charles N.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2008, 117 (07): : 477 - 483
  • [44] The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial
    Ra, Seung Won
    Kim, Sun Young
    Lim, Yun Young
    Park, Shin Jung
    Rhee, Chin Kook
    Kim, Deog Kyeom
    Park, Yong Bum
    Lee, Chang Youl
    Yoon, Hyoung Kyu
    Park, Jeong-Woong
    Yoo, Kwang Ha
    JOURNAL OF THORACIC DISEASE, 2021, 13 (01) : 1 - U12
  • [45] ACRIVASTINE VERSUS TERFENADINE IN THE TREATMENT OF SYMPTOMATIC DERMOGRAPHISM - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    BOYLE, J
    MARKS, P
    GIBSON, JR
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1989, 17 : B9 - B13
  • [46] Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study
    Chen, Ya-qin
    Zhao, Shui-ping
    Zhao, Yu-hong
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (05) : 692 - 697
  • [47] Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
    Wunderink, RG
    Cammarata, SK
    Oliphant, TH
    Kollef, MH
    CLINICAL THERAPEUTICS, 2003, 25 (03) : 980 - 992
  • [48] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Hiromi Rakugi
    Kazuomi Kario
    Masako Yamaguchi
    Takayoshi Sasajima
    Hiromi Gotou
    Jack Zhang
    Hypertension Research, 2022, 45 : 824 - 833
  • [49] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Rakugi, Hiromi
    Kario, Kazuomi
    Yamaguchi, Masako
    Sasajima, Takayoshi
    Gotou, Hiromi
    Zhang, Jack
    HYPERTENSION RESEARCH, 2022, 45 (05) : 824 - 833
  • [50] A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
    Wun, Ted
    Soulieres, Denis
    Frelinger, Andrew L.
    Krishnamurti, Lakshmanan
    Novelli, Enrico M.
    Kutlar, Abdullah
    Ataga, Kenneth I.
    Knupp, Charles L.
    McMahon, Lillian E.
    Strouse, John J.
    Zhou, Chunmei
    Heath, Lori E.
    Nwachuku, Chuke E.
    Jakubowski, Joseph A.
    Riesmeyer, Jeffrey S.
    Winters, Kenneth J.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
12345